Author

J. Guevara-Coto

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Pise· 2 shared B. Patterson· 2 shared E. B. Francisco· 2 shared E. Long· 2 shared H. Rodrigues· 2 shared J. Mora· 2 shared P. Parikh· 2 shared R. Yogendra· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Pise

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) Up to 15 Months Post-Infection

B. Patterson, E. B. Francisco, R. Yogendra, E. Long, A. Pise, H. Rodrigues, E. Hall, M. Herrera, P. Parikh, J. Guevara-Coto, T. Triche, P. Scott, S. Hekmati, D. Maglinte, X. Chang, , J. Mora

This study finds SARS-CoV-2 S1 protein in non-classical monocytes in PASC patients up to 15 months post-infection, but not full-length viral RNA.

bioRxiv · Jun 25, 2021Immunology

MYC dosage compensation is mediated by miRNA-transcription factor interactions in aneuploid cancer

M. S. Acon, C. Geiss, J. Torres-Calvo, D. Bravo-Estupinan, G. Oviedo, J. L. Arias-Arias, L. A. Rojas-Matey, E. Baez, G. Vasquez-Vargas, Y. Oses-Vargas, J. Guevara-Coto, A. Segura-Castillo, F. Siles-Canales, S. Quiros-Barrantes, A. Regnier-Vigouroux, , R. M. Mora-Rodriguez

This study identifies miRNA-transcription factor interactions that mediate MYC dosage compensation in aneuploid cancer, showing a negative correlation with patient survival in breast cancer.

bioRxiv · Apr 20, 2021Cancer Biology

Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning

B. Patterson, J. Guevara-Coto, R. Yogendra, E. B. Francisco, e. long, A. Pise, H. Rodrigues, P. Parikh, J. Mora, R. A. Mora-Rodriguez

The paper uses machine learning to predict and distinguish phases of COVID-19 severity and chronicity based on immune profiles from different patient groups.

bioRxiv · Dec 16, 2020Immunology